Quarterly report pursuant to Section 13 or 15(d)

Loss per share - Antidilutive shares (Details)

v3.22.2.2
Loss per share - Antidilutive shares (Details) - shares
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Share options        
Antidilutive securities        
Potentially dilutive equity instruments excluded from the diluted loss per share (in shares) 152,427,845 115,924,296 152,427,845 115,924,296